Editorial: Mendelian randomization and cardiovascular remodeling

Front Pharmacol. 2025 Mar 25:16:1593325. doi: 10.3389/fphar.2025.1593325. eCollection 2025.

Jianxin Qiang^#¹, Jia Yang^#², Yanwu Liu^#¹, Ji Zhang^#³, Hao Sun^#⁴, Lijuan Li^#¹, Duo Wang^#³, Yanping Liu⁵, Panpan Hao^{1

6}

¹ Department of Cardiology, Wuzhong People's Hospital Affiliated to Ningxia Medical University, Wuzhong, Ningxia, China.
² 120 First-aid Call Center, Wuzhong People's Hospital Affiliated to Ningxia Medical University, Wuzhong, Ningxia, China.
³ Department of Neurology, Wuzhong People's Hospital Affiliated to Ningxia Medical University, Wuzhong, Ningxia, China.
⁴ Department of Teaching and Research, Wuzhong People's Hospital Affiliated to Ningxia Medical University, Wuzhong, Ningxia, China.
⁵ Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
⁶ Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

^# Contributed equally.

No abstract available

Keywords: atheroclerosis; cardiovascular remodeling; diabetes; heart failure; mendelian randomization.

Publication types